| Brand Name | MAXIMA PRO 2 |
| Common Device Name | HANDPIECE |
| Manufacturer (Section D) |
| TTBIO CORP |
| 2f, no. 7, 6th road |
| industry pa |
| taichung, 40755 |
| TW 40755 |
|
| MDR Report Key | 17008293 |
| Report Number | 3007007357-2023-00004 |
| Device Sequence Number | 7538428 |
| Product Code |
EFB
|
| UDI-Device Identifier | 00304040090046 |
| UDI-Public | 00304040090046 |
| Combination Product (Y/N) | N |
| Initial Reporter State | CA |
| Initial Reporter Country | US |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Serviced by Third Party (Y/N) | Unknown |
| Reporter Type |
Importer
|
| Initial Reporter Occupation |
Non-Healthcare Professional
|
| Type of Report
| Initial |
| Report Date (Section B) |
05/25/2023 |
| Report Date (Section F) |
05/25/2023 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
Health Professional
|
| Device Model Number | MAXIMA PRO 2 STD HEAD |
| Device Catalogue Number | 570-1072 |
| Was Device Available for Evaluation? |
Device Returned to Manufacturer
|
| Date Returned to Manufacturer | 05/25/2023 |
| Was the Report Sent to FDA? |
Yes
|
| Distributor Facility Aware Date | 05/04/2023 |
| Device Age | 5 MO |
| Event Location |
Outpatient Treatment Facility
|
| Date Report to Manufacturer | 05/25/2023 |
| Initial Date Received by Manufacturer | Not provided |
| Initial Report FDA Received Date | 05/25/2023 |
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Patient Sequence Number | 1 |
| Outcome Attributed to Adverse Event |
Other;
|
| Patient Sex | Male |
| Date Report Sent to FDA | 05/25/2023 |
|
|